|
|
|
|
AnaMar news |
New COMP ELISA Focus letter |
| |
| Focus letter 6 - Recent data suggest the existence of different phenotypic subsets of RA at clinical onset and elevated serum COMP levels should be interpreted in relation to this new approach |
In recent years, data have been published to suggest that anti-CCP positive and anti-CCP negative RA constitute two different phenotypic manifestations of RA with respect to both clinical prognosis and underlying disease mechanisms.
To read Focus letter 6, or previous issues, please visit www.compelisa.com |
|
|
|
|
|
|
|